We believe our new website will connect visitors with the information about Lyne Laboratories they came to find. The website is designed so that one can easily navigate and capture the information being sought. We realize that no website is perfectly designed, but we believe we have achieved a “well designed” website that will fulfill its purposes. We have incorporated a real time NEWS page to keep interested parties in tune with Lyne’s up to … Continue reading
“In recent years Lyne Laboratories has changed its business model from exclusively contract manufacturing as a Contract Manufacturing Organization (CMO) to both contract services and proprietary generic pharmaceuticals. Lyne’s generics program required the establishment of a new Research & Development Department (R&D), whose staff is currently working in the … Continue reading
Who we are
Lyne has been providing contract manufacturing services to mid-size and large ethical pharmaceutical companies, small biotech start-ups, and virtual companies for more than 35 years. We specialize in the manufacture of oral liquids, powders, semi-solids, tablets and liquid unit-dose packaging. Lyne also offers manufacturing services for scheduled drugs and alcohol formulations.
Lyne’s services include:
- Clinical manufacturing – Late Stage Phase III
- Technical Transfer
- Commercial manufacturing
… Continue reading
Lyne Laboratories has opened a high-tech facility for the manufacture of large volumes of high-concentration flammable products.It marks the completion of the first phase of a three-phase expansion of its pharmaceutical manufacturing facility in Brockton, MA.
The expansion includes a flammable tank farm housed in a state-of-the-art modular explosion-proof building that is designed specifically for the manufacture of high-alcohol content or solvent-based drug products. The expansion also includes a separate storage building for the flammable … Continue reading
Lyne Laboratories is expanding its pharmaceutical manufacturing facility in Brockton, MA with a three-phase plan to be completed in 2005. The expansion, which totals 50,000 sq ft., will allow Lyne to manufacture large volumes of high-concentration flammable products, and to enhance its modern, cGMP facility.
Phase 1 adds a flammable tank farm and storage building to the Lyne facility. Phases 2 and 3 expand the existing warehouse and manufacturing areas.
Phase 1 is expected to … Continue reading
Singular Sensation. Lyne’s new PET (polyethylene terepthalate) cup featured in article about patient compliance.For children and geriatric patients who have trouble swallowing tablets and capsules, liquid unit-dosing can be a lifesaving option. US hospitals plagued by roughly 100,000 annual deaths from medication errors consider liquid unit-dosing optional; soon, it will be mandatory…. (Reprint from Pharmaceutical Formulation & Quality magazine)
Click here to view the article.
… Continue reading
For caregivers in pediatric wards and nursing homes it ‘s a daily challenge to get patients to take their medicines: Tablets must be crushed into smaller pieces and capsule contents mixed with food or disguised in beverages. Difficulty swallowing tablets and capsules is common for these populations. Surprisingly, this problem also affects the general adult population…. (Reprint from Pharmaceutical Formulation & Quality magazine)
Click here … Continue reading
Lyne Cited as the Future of Contract Manufacturing by Pharmaceutical Processing
Lyne’s manufacturing plant was recently highlighted in a Pharmaceutical Processing article about optimizing accuracy, changeover, technological advancements, operator interface and sanitation…
Click Here for the Full Article.
You may need to download the free Acrobat Reader